AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
(Updated - May 21, 2024 11:56 AM EDT)
UK’s biggest drugmaker says it plans to launch 20 major new medicines before the end of the decade